A CLINICAL RESEARCH ON UTHIRAVATHA SURONITHAM (RHEUMATOID ARTHRITIS) WITH SIDDHA DRUG VATHA RATCHASAN MATHTHIRAI
Phase 2
- Conditions
- Health Condition 1: null- MALE AND FEMALE WITH MORNING STIFFNESS AND THREE OR MORE JOINT PAI
- Registration Number
- CTRI/2017/11/010357
- Lead Sponsor
- GOVERNMENT SIDDHA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Age 18 to 50 years
Willing to participate in trial and signing in consent proforma
History of Rheumatoid Arthritis (Anti CCP and RA positive)
Morning stiffness
Three or more join pain
Swelling
Exclusion Criteria
Rheumatic fever
Psoriatic arthropathica
Gouty arthritis
Systemic lupus erythematous
H/O of Sulphur allergy
Progressive systemic sclerosis(PSS)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It mainly assessed by reduce symptoms like pain swelling morning stiffness <br/ ><br>Hopefully it brings prognostic changes in CRP RA factor X rayTimepoint: 48 days
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameterss before and after treatmentTimepoint: 48 days